Chemoinformaics analysis of CAPRYLIC-ACID-METHYL-ESTER
| Molecular Weight | 290.363 | nRot | 8 |
| Heavy Atom Molecular Weight | 268.187 | nRig | 12 |
| Exact Molecular Weight | 290.163 | nRing | 2 |
| Solubility: LogS | -3.579 | nHRing | 1 |
| Solubility: LogP | 3.475 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 4 | APOL | 45.9954 |
| nHD | 1 | BPOL | 27.8226 |
| QED | 0.6 |
| Synth | 2.011 |
| Natural Product Likeliness | -0.746 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.056 |
| Pgp-sub | 0.701 |
| HIA | 0.004 |
| CACO-2 | -4.634 |
| MDCK | 0.0000234 |
| BBB | 0.825 |
| PPB | 0.813107 |
| VDSS | 0.894 |
| FU | 0.104083 |
| CYP1A2-inh | 0.887 |
| CYP1A2-sub | 0.875 |
| CYP2c19-inh | 0.903 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.72 |
| CYP2c9-sub | 0.117 |
| CYP2d6-inh | 0.471 |
| CYP2d6-sub | 0.117 |
| CYP3a4-inh | 0.65 |
| CYP3a4-sub | 0.226 |
| CL | 8.538 |
| T12 | 0.863 |
| hERG | 0.034 |
| Ames | 0.138 |
| ROA | 0.025 |
| SkinSen | 0.259 |
| Carcinogencity | 0.762 |
| EI | 0.053 |
| Respiratory | 0.344 |
| NR-Aromatase | 0.064 |
| Antiviral | Yes |
| Prediction | 0.655692 |